Drug Trial Radar · NCT00814073
Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis
Last checked: Nov 20, 2026Latest source record: Dec 3, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
135
Actual
Start
Dec 2008
Primary completion
Nov 2015
Study completion Nov 2015
Sponsor
- Lead sponsor
- AB ScienceIndustry
- Sponsor type
- Industry
- First posted
- Dec 23, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this study is to compare the safety and efficacy of masitinib (AB1010) to placebo in patients with mastocytosis with handicap.
Conditions
- Indolent Systemic Mastocytosis
Interventions
MasitinibDrug
Masitinib 6 mg/kg/day
PlaceboDrug
Matching placebo
Best Supportive CareOther
Optimal concomitant symptomatic treatments. Includes: H1- and H2-antihistamines, proton pump inhibitors (PPI), sodium cromoglicate, antidepressants, leukotriene antagonists, interferon-alpha, 2-CdA, and corticosteroids.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Cumulative response (4R75%)Time frame: 24 weeks
Locations
24 sites in 2 countries. Site status is shown where the registry gives one.
UC Davis Health System , Department of Dermatology
Sacramento, California
MD Anderson Cancer Centre
Houston, Texas
CHU d'Amiens
Amiens, France
Hôpital Avicenne
Bobigny, France
CHU de Brest
Brest, France
CHU de Caen
Caen, France
CHU Clermont Ferrand
Clermont-Ferrand, France
Hôpital Claude Huriez
Lille, France
CHU Dupuytren
Limoges, France
Hôpital Ambroise Paré
Marseille, France
Hôpital Nord
Marseille, France
Hôpital Central
Nancy, France
CHU Hôtel Dieu
Nantes, France
Hôpital l'Archet II
Nice, France
Hôpital Necker
Paris, France
Hôpital Tenon
Paris, France
CHU Lyon Sud
Pierre-Bénite, France
Centre Hospitalier Lyon Sud
Pierre-Bénite, France
CHU Milétrie
Poitiers, France
CHU Hôpital Sud
Rennes, France
CHU de Saint-Etienne
Saint-Etienne, France
Hôpital Purpan
Toulouse, France
Hôpital Bretonneau
Tours, France
Hôpital des Hauts Clos
Troyes, France
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.